(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 3. Loss of cvl2 only weakly affects chordin/dino
mutants. (A-D) Lateral views of 32 hpf embryos; different classes
of dino mutants displaying an increasing loss of ventral tail fin
tissue (arrows in C,D). Percentages indicate the fraction of embryos
displaying the shown tail fin phenotype among uninjected mutants
(n=132) and mutants from the same crosses injected with cvl2
MO (n=215). Injection of cvl2 MO2 increases the percentage
of dino mutants with class III phenotype, reflecting a stronger
dorsalization within the ventral tissue fin tissue. (E,F)
krox20 staining, five-somite stage, animal view, anterior leftwards.
cvl2 MO1 clearly expands the neuroectoderm in
ogontm305 mutants (F, 41/42 embryos), but only has a weak
effect in chordin morphants (E, 55/55 embryos), indicating that
ventralized traits of chordin can neither be rescued nor enhanced upon loss of
Cvl2 function.